Intelligence Platform
Patents
Browse 65 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11135247
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted patentUS 11118177
Materials and methods for treatment of Usher syndrome type 2A and/or non-syndromic autosom
granted patentUS 11118196
Universal donor cells
granted patentUS 11118195
Universal donor cells
granted patentUS 11116798
Universal donor cells
granted patentUS 11116797
Universal donor cells
granted patentUS 11104918
Universal donor cells
granted patentUS 11083799
Materials and methods for treatment of hereditary haemochromatosis
granted patentUS 11071755
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted patentUS 11072792
Materials and methods for treatment of usher syndrome type 2A
granted patentUS 11013767
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted patentUS 10995328
Materials and methods for treatment of autosomal dominant cone-rod dystrophy
granted patentUS 10881689
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted patentUS 10857184
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted patentUS 10736919
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted patentUS 10729725
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted patentUS 10662425
Materials and methods for treatment of autosomal dominant retinitis pigmentosa
granted